LBH589, A Hydroxamic Acid-Derived HDAC Inhibitor, is Neuroprotective in Mouse Models of Huntington’s DiseaseVanita Chopra(Harvard University), Steven M. Hersch(Harvard University)Journal of Huntington s DiseaseDecember 15, 201610.3233/jhd-160226Cited by 31SaveCiteExport RISWatch citationsRelated PapersThe mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington's disease|Molecular Neurodegeneration|2010|96